Radiation Drugs – Still a Hot Topic

Citation

Moos, W. H., & Shankar, G. N. (2014). Radiation drugs – still a hot topic. Drug Development Research, 75(1), 1-2. doi: 10.1002/ddr.21160

Abstract

Who knew when the March 2011 earthquake and tsunami in Japan led to a meltdown of the Fukushima Daiichi nuclear plant that it would represent the largest nuclear disaster since Chernobyl in 1986? Since then, a range of articles in both professional journals and the lay press have continued to appear with great regularity. On the occasion of the second anniversary of the Fukushima disaster, it was reported inScience magazine that evacuees were still waiting to go home, but fortunately that radionuclide exposure, at least to radiocesium ingestion, had been limited [Normile, 2013a, 2013b]. A PubMed search for “Fukushima radiation” on May 26, 2013, returned nearly 650 articles, 36 since March 2013. Searching the Wall Street Journal for the same terms on the same date retrieved 15 articles since March 2013.


Read more from SRI

  • Banner and attendees at the IEEE Hard Tech Venture Summit

    Cultivating hard tech startups that scale

    IEEE’s Hard Tech Venture Summit convened innovators at SRI to refine strategies and build new networks.

  • Patient going into a MRI

    Bringing surgical tools inside the MRI

    Drawing on SRI’s unique innovation ecosystem, the startup Medical Devices Corner is seeking to improve cancer surgery by advancing MRI-safe teleoperation.

  • Christopher Mims and Susan Patrick

    PARC Forum: How to AI

    The Wall Street Journal tech columnist Christopher Mims and SRI Education’s Susan Patrick discuss how AI can strengthen human agency.